This report presents a case where a patient was initially diagnosed with stage IV cancer and had experienced significant survival with serial ALK TKI systemic therapy with appropriate interventional with aggressive local therapies to address oligoprogression, first with SBRT and later with surgical resection of the primary site. The gene discussed is ALK; the disease is cancer.